These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10209926)

  • 1. A case of multiple sebaceous epithelioma: analysis of microsatellite instability.
    Ueda M; Wang Y; Sugimura H; Tamura S; Kondoh M; Ichihashi M
    J Dermatol; 1999 Mar; 26(3):178-82. PubMed ID: 10209926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muir-Torre syndrome: role of the dermatopathologist in diagnosis.
    Curry ML; Eng W; Lund K; Paek D; Cockerell CJ
    Am J Dermatopathol; 2004 Jun; 26(3):217-21. PubMed ID: 15166510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
    Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
    J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
    Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
    J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sebaceous Neoplasms.
    Flux K
    Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
    Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
    Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muir-Torre syndrome: clinical features and molecular genetic analysis.
    Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
    Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.
    Machin P; Catasus L; Pons C; Muñoz J; Conde-Zurita JM; Balmaña J; Barnadas M; Martí RM; Prat J; Matias-Guiu X
    J Cutan Pathol; 2002 Aug; 29(7):415-20. PubMed ID: 12139636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Muir-Torre syndrome family.
    Serleth HJ; Kisken WA
    Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
    Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
    Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies.
    Warschaw KE; Eble JN; Hood AF; Wolverton SE; Halling KC
    J Cutan Pathol; 1997 Sep; 24(8):511-8. PubMed ID: 9331898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muir-Torre syndrome.
    Navi D; Wadhera A; Fung MA; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):4. PubMed ID: 16962019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muir-Torre syndrome.
    Ponti G; Ponz de Leon M
    Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
    Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
    Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
    Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
    Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
    Neelakantan IV; Di Palma S; Smith CE; McCoombe A
    Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.